Remond J A Fijneman - Division of Molecular Genetics

基本信息

Career Trajectory

Bio

Remond J A Fijneman is Principal Investigator and Associate Group Leader of the Translational Gastrointestinal Oncology group at the Netherlands Cancer Institute, Amsterdam. Research focuses on identification, validation and implementation of biomarkers for colorectal cancer: 1. DNA Structural Variants, using organoid models and tumor tissues. 2. cell-free circulating tumor DNA as prognostic, predictive, and disease monitoring biomarkers, using clinically well-defined patient cohorts.

Research Interests

Papers共 245 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Tumor Break Load Quantitates Structural Variant-Associated Genomic Instability with Biological and Clinical Relevance Across Cancers

Soufyan Lakbir, Renske de Wit,Ino de Bruijn,Ritika Kundra,Ramyasree Madupuri,Jianjiong Gao,Nikolaus Schultz,Gerrit A Meijer,Jaap Heringa,Remond J A Fijneman,Sanne Abeln

NPJ precision oncologyno. 1 (2025): 140-140

Cited0Views0WOSBibtex

Longitudinal Ctdna Measurements for Treatment Response Monitoring in Patients with Metastatic Colorectal Cancer Undergoing Systemic Therapy: the ORCA Trial

Denise van Steijn,George Laliotis, Erik Anthony Spickard,Suzanna J. Schraa,Frederieke H. van der Baan,Cornelis J. A. Punt,Daan van den Broek,Shruti Sharma,Himanshu Sethi,Minetta C. Liu,Adham A. Jurdi,Niels F. M. Kok,Miriam Koopman,Geraldine R. Vink,Remond Fijneman

JOURNAL OF CLINICAL ONCOLOGY（2025）

Cited0Views0Bibtex

Feasibility and Safety of Single-Fraction Sub-Ablative Radiotherapy with Systemic Therapy in Colorectal Cancer Patients with ≤ 10 Metastases: A Multicenter Pilot Study (NCT05375708)

K. Zwart,M. N. G. J. A. Braat, F. H. van der Baan,A. M. May,J. M. L. Roodhart, D. Al-Toma, J. M. M. B. Otten,M. Los, T. Oostergo,R. J. A. Fijneman, J. M. van Dodewaard-de Jong,C. J. A. Punt,G. Meijer,J. J. W. Lagendijk,M. Koopman,M. Intven,G. M. Bol

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY（2024）

Cited0Views0WOSBibtex

Chromatin Landscapes of Colorectal Cancer Development and Cfdna Fragmentation

Nicholas A. Vulpescu,Zachariah H. Foda, Pieter H. Wisse,Jamie E. Medina,Vilmos Adleff,Remond J. Fijneman,Robert B. Scharpf,Gerrit A. Meijer,Beatriz Carvalho,Victor E. Velculescu

Cancer Research（2024）

Cited0Views0Bibtex

Employing Widening Funds to Address Inequity in Cancer Research - Example of the STEPUPIORS Collaborative Rectal Cancer Project

Milena Cavic,Ana Djuric,Mladen Marinkovic,Aleksandra Stanojevic,Miljana Tanic, Snezana Bjelogrlic,Jelena Spasic,Ana Damjanovic,Marija Djordjic Crnogorac,Ana Vuletic,Katarina Mirjacic Martinovic,Marko Radulovic,Suzana Stojanovic-Rundic,Ana Krivokuca,Radmila Jankovic,Sergi Castellvi-Bel,Jerome Zoidakis,Remond J. Fijneman

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Cancer Treatment Monitoring Using Cell-Free DNA Fragmentomes

R. Fijneman,L. Rinaldi,Z. Skidmore,B. Alipanahi,L. Keefer,I. van 't Erve,K. Lumbard,J. Carey,B. Chesnick,S. Cristiano,N. Dracopoli,R. Scharpf,G. Meijer,A.I.C. Leal,V. Velculescu

Annals of Oncology（2024）

Cited0Views0WOSNATUREBibtex

264: SBRT in Colorectal Cancer Patients with 1-10 Metastases: a Multicenter Pilot Study (NCT05375708)

Koen Zwart,Manon N.G.J.A. Braat,Frederieke H. van der Baan,Anne M. May,Jeanine Roodhart, Hans-Martin M.M.B. Otten,Maartje Los, Tanja Oostergo,Remond Fijneman,Joyce M. van Dodewaard- de Jong,Cornelis J.A. Punt,Gert Meijer,Jan J.W. Lagendijk,Miriam Koopman,Martijn Intven,Guus M. Bol

Radiotherapy and Oncology (2024): S1471-S1474

Cited0Views0Bibtex

Methylenetetrahydrofolate Reductase Polymorphic Variants C677T and A1298C in Rectal Cancer in Slavic Population: Significance for Cancer Risk and Response to Chemoradiotherapy

Aleksandra Stanojevic,Jelena Spasic,Mladen Marinkovic,Suzana Stojanovic-Rundic,Radmila Jankovic,Ana Djuric,Jerome Zoidakis,Remond J. A. Fijneman,Sergi Castellvi-Bel,Milena Cavic

FRONTIERS IN GENETICS（2024）

Cited2Views0WOSBibtex

Monitoring Treatment Response in Patients with Metastatic Colorectal Cancer Using Cfdna Fragmentomics Testing: the DOLPHIN Trial

Denise E. van Steijn,Remond J. Fijneman,Geraldine R. Vink,Jeanine M. Roodhart,Miriam Koopman,Max J. Lahaye, Manon N. G. Braat,Veerle M. Coupe, Daan A. van den Broek,Gerrit A. Meijer, Haoyue Wang,Marjolein J. Greuter, Birgit I. Lissenberg-Witte,Lorenzo Rinaldi, E. Peters,Alissa Konicki,Nicholas C. Dracopoli,Niels F. Kok,Victor E. Velculescu

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

MEDOCC-CrEATE Trial: Feasibility of Measuring Circulating Tumor DNA after Surgery to Guide Adjuvant Chemotherapy in Stage II Colon Cancer Patients

Ingrid Franken,Suzanna Schraa,Karlijn van Rooijen, Dave van der Kruijssen,Carmen Rubio-Alarcon,Steven Ketelaars, Sietske van Nassau, Teunise Snetselaar, Bregje Adriaans,Jillian Phallen,Sam Angiuoli,Amy Greer,Ellen Verner,Veerle Coupe,Helena Verkooijen,Miranda van Dongen,Linda Bosch,Mirthe Lanfermeijer,Daan van den Broek,Gerrit Meijer,Victor Velculescu,Mark Sausen,Miriam Koopman,Remond Fijneman,Geraldine Vink

CANCER RESEARCH（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn